Dealing with Sclerotherapy Extravasation - Novel method to deactivate STDS and relieve operator stress

This submission has open access
Submission ID :
GEST2021-96
Submission Type
Submission Topic
Purpose :
Extravasation of STDS during percutaneous sclerotherapy of varicosities can result in tissue necrosis leading to ulcerations. Various agents such as normal saline, hyaluronidase, etc. were being used as a bailout to contain the damage caused by extravasated STDS. We propose a novel no-cost easily available agent which can be used to deactivate the extravasated STDS thereby preventing tissue damage.
Materials & Methods :
20 consecutive patients of varicose veins who underwent percutaneous sclerotherapy and had an incidence of extravasation during the procedure were included in this study. The novel agent was locally injected under real-time ultrasound guidance as soon as extravasation of STDS was noticed. The patients were followed up for a period of 2 months.
Results :
The novel agent could be available on an instant basis during the procedure. The average time duration between extravasation and injection of the novel agent at the site of interest was less than 5 minutes. None of the 20 patients developed skin necrosis/ulcers during the follow-up period.
Conclusions :
Accidental extravasation of the sclerosing agent can cause avoidable suffering to the patient and anguish for the operator. This readily available deactivating agent prevents skin necrosis and enables the operator to rest easily without the constant apprehension of possible skin necrosis and operator heartache.
Oral Abstract Presentation :
If the file does not load, click here to open/download the file.
Founder, Consultant
,
The Vein Center
The Vein Center
The Vein Center
The Vein Center
The Vein Center
The Vein Center
The Vein Center

Similar Abstracts by Type

Submission ID
Submission Title
Submission Topic
Submission Type
Primary Author
GEST2021-90
Immuno-Oncology
Oral Abstract
Mr. Tushar Garg
GEST2021-139
Pre-Clinical/New Devices/Lab Sciences
Oral Abstract
Chen Guo
GEST2021-122
Women’s Health
Oral Abstract
Mr. Maciej Szmygin
GEST2021-110
Other
Oral Abstract
Mr. Eliseo García
57 hits